How many studies have been conducted on Etodolac?

BiohacksAI has indexed 296 PubMed studies on Etodolac, including 56 randomized controlled trials (RCTs). 49% of studies involve human subjects.

What are the main research areas for Etodolac?

The primary research domains for Etodolac are 🔬 Inflammation, 🦴 Bone & Joint, 💊 Pain. This is based on analysis of 296 PubMed studies using the BiohacksAI evidence platform.

Etodolac

A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (POSTOPERATIVE PAIN).

296+ PubMed studies analyzed · 56 RCTs · Evidence Score: 51.2

Research Domains

Etodolac has been studied across 14 research domains including 🔬 Inflammation, 🦴 Bone & Joint, 💊 Pain, 🔬 Oncology, 🫁 Liver & Detox. The primary research focus is 🔬 Inflammation with 57% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Etodolac, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

3-Iodobenzylguanidine

3 shared targets

Loading evidence profile...

This evidence profile for Etodolac is generated deterministically from 296 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.